Latest 10-Q quarterly reports

Atea Pharmaceuticals reported its Q2 2026 financial results, highlighting progress in its HCV and HEV programs, with topline results from the C-FORWARD Phase 3 trial anticipated in early Q1 2027.

FinWise Bancorp reported a decrease in net income for the second quarter of 2026 compared to the prior year, primarily driven by a substantial increase in the provision for credit losses.

Crown Reserve Acquisition Corp. I reports on its Q2 2026 financial status, highlighting progress on its business combination with Carvix, Inc., while noting ongoing operational funding reliance on its sponsor.

Crown Crafts Inc. announced a significant turnaround in net income for the three-month period ended June 28, 2026, driven by a substantial tariff refund and increased sales in its bibs, toys, and disposable products segment.

American Exceptionalism Acquisition Corp. A reports net income of $2.82 million for Q2 2026, primarily from interest on trust account investments, while continuing its search for a business combination.

Sizzle Acquisition Corp. II files its Q2 2026 Form 10-Q, detailing financial status and progress towards its business combination with Trasteel.

Resideo Technologies announced Q2 2026 results with revenue up 2.0% to $1.98 billion and improved gross margins, while navigating the significant strategic separation of its ADI Global Distribution business.

Journey Medical Corporation's Q2 2026 results show a 23% total revenue increase driven by Emrosi, though net losses persist, raising going concern questions.

Battalion Oil Corporation filed its Form 10-Q for the quarter ended June 30, 2026, detailing a net loss, significant debt refinancing, and ongoing capital raise efforts.

Power REIT's Q2 2026 Form 10-Q reveals a net loss attributable to common shareholders of $784,138 for the first six months, alongside a significant accumulated deficit, while also detailing asset sales and a reverse stock split.

Commercial Bancgroup, Inc. announced a 14.8% increase in net income for the second quarter of 2026, driven by reduced interest expenses and growth in net interest income.

Hashdex Nasdaq CME Crypto Index ETF's Q2 2026 report reveals a substantial decline in Net Asset Value per Share and significant unrealized losses on its crypto asset holdings.

Regional Health Properties, Inc. announced its Q2 2026 results, showing increased revenues driven by segment integration but also a widening net loss and continued focus on liquidity management.

American Strategic Investment Co. reports continued operational challenges and significant financial distress, including multiple loan defaults and ongoing foreclosure proceedings, despite some revenue stabilization.

Red Robin Gourmet Burgers, Inc. reported a decrease in total revenues and a net loss for the year-to-date period in its Q2 2026 filing, impacted by restaurant closures and increased selling expenses.

Vivos Inc. reports progress on FDA approvals for its RadioGel therapy and growth in its IsoPet animal division, but continues to face significant net losses and concerns about its going concern status.

Vyome Holdings, Inc. filed its Q2 2026 Form 10-Q, detailing significant net losses, increased R&D expenses, and a continued reliance on external financing to sustain operations.

Artelo Biosciences filed its Q2 2026 Form 10-Q, detailing ongoing R&D efforts and significant cash burn, raising substantial doubt about its ability to continue as a going concern.

Linkhome Holdings Inc. reported a net loss of $128,505 for the three months ended June 30, 2026, with revenues increasing by 12.76% to $5,411,777, though the six-month period saw a revenue decrease and a larger net loss.

White Pearl Acquisition Corp. reports on its financial status for the quarter ended June 30, 2026, highlighting its ongoing efforts to identify and complete a business combination.

Stellar V Capital Corp. reports on its financial condition and operational status for the quarter ended June 30, 2026, highlighting its ongoing search for a business combination and its liquidity position.

Lucid Diagnostics Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting increased revenue but also substantial net losses and significant cash burn, leading to a going concern warning.

Central Plains Bancshares, Inc. announced its first-quarter financial results, showcasing an increase in net income and a robust net interest margin.

Oaktree Acquisition Corp. III Life Sciences files its Q2 2026 10-Q, reporting net income driven by interest income and detailing its ongoing search for a business combination target.

Blueport Acquisition Ltd reports on its Q2 2026 financial status, highlighting progress on its merger agreement with SINGAUTO Inc. while acknowledging substantial doubt regarding its ability to continue as a going concern.

International Tower Hill Mines Ltd. reports substantial progress on its Livengood Gold Project, bolstered by a significant capital raise and advancements in feasibility studies.

ASPAC III Acquisition Corp. reports continued operational inactivity and significant challenges, including a potential Nasdaq delisting and substantial doubt regarding its going concern status, as it seeks a business combination.

Cartesian Growth Corporation IV has filed its quarterly report for the period ending June 30, 2026, detailing the successful completion of its Initial Public Offering and the significant capital raised.

Datacentrex, Inc. filed its Q2 2026 Form 10-Q, detailing a substantial net loss driven by increased operating expenses and digital asset market volatility, while revenues remained relatively stable.

Enovix Corporation reported a 21% increase in revenue for Q2 2026 compared to the prior year, driven by defense sector sales, but continued to experience significant operating losses and cash burn.